Correction: The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan
Stefan Kohler, Norman Sitali, Jay Achar, Nicolas Paul

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical Quality and Counterfeiting · Pharmaceutical Economics and Policy
There are errors in the Funding and Competing Interests statements. The correct statements are:
Funding: Médecins Sans Frontières (MSF) provided support for the study in the form of salary for NS. The specific roles of this author are articulated in the ‘Authors’ section. MSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: SK and NP consulted for Médecins Sans Frontières. NS works as a Medical Operations Manager for MSF, and thus received support from MSF in the form of salary. JA worked as TB medical advisor for the MSF Manson Unit. SK is an Academic Editor for PLOS Global Public Health. This does not alter our adherence to PLOS Global Public Health policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.
There is an error with the “View Article” link for Reference 39. The correct link is: https://doi.org/10.34133/2021/9813732
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Kohler S, Sitali N, Achar J, Paul N (2022) The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan. PLOS Glob Public Health 2(8): e 0000567. 10.1371/journal.pgph.0000567 36962528 PMC 10021759 · doi ↗ · pubmed ↗
